To examine whether KD of APE1 can also enhance sensitivity to 5-FU and oxaliplatin and suppress PDAC tumor growth in vivo, we utilized a tumor xenograft model with MIA PaCa-2APE1shRNA cells. Here, APEX1 is linked to neoplasm.